Sunvozertinib overcoming resistance to afatinib and osimertinib in lung adenocarcinoma harboring an EGFR exon 18 DelE709_T710insD mutation.

J Transl Med

Department of Medical Thoracic Oncology, Hangzhou Institute of Medicine (HIM), Zhejiang Cancer Hospital, Chinese Academy of Sciences, No. 1 East Banshan Road, Gongshu District, Hangzhou, 310022, Zhejiang, China.

Published: August 2024

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11323653PMC
http://dx.doi.org/10.1186/s12967-024-05522-yDOI Listing

Publication Analysis

Top Keywords

sunvozertinib overcoming
4
overcoming resistance
4
resistance afatinib
4
afatinib osimertinib
4
osimertinib lung
4
lung adenocarcinoma
4
adenocarcinoma harboring
4
harboring egfr
4
egfr exon
4
exon dele709_t710insd
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!